Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · IEX Real-Time Price · USD

1.610

-0.120 (-6.94%)

At close: Apr 26, 2024, 4:00 PM

1.720

+0.110 (6.83%)

After-hours: Apr 26, 2024, 6:10 PM EDT

Adial Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	7	2	6	56	24	25	34	-	-
Market Cap Growth	-	-60.76%	-89.70%	131.97%	-2.80%	-25.92%	-	-	-
Enterprise Value	4	-1	2	50	20	18	30	1	0
PE Ratio	-0.44	-0.44	-0.45	-2.89	-2.22	-2.89	-2.89	-	-
PB Ratio	1.60	0.56	1.76	15.98	6.06	3.48	7.56	-	-
P/FCF Ratio	-0.33	-0.33	-0.52	-4.67	-3.17	-3.92	-13.44	-	-
P/OCF Ratio	-0.33	-0.33	-0.52	-4.69	-3.17	-3.92	-13.44	-	-
EV/EBITDA Ratio	0.11	0.11	-0.14	-2.58	-1.81	-2.11	-2.84	-0.67	-0.27
EV/EBIT Ratio	0.11	0.11	-0.14	-2.58	-1.81	-2.11	-2.84	-0.67	-0.27
EV/FCF Ratio	0.08	0.08	-0.16	-4.18	-2.59	-2.85	-11.89	-1.36	-0.41
Debt / Equity Ratio	-	-	-	0.07	-	-	-	-0.69	-2.26
Debt / EBITDA Ratio	-	-	-	-0.01	-	-	-	-0.69	-0.57
Debt / FCF Ratio	-	-	-	-0.02	-	-	-	-1.39	-0.85
Quick Ratio	4.33	4.33	2.23	2.23	2.92	12.57	15.00	0.02	0.48
Current Ratio	4.90	4.90	2.67	2.37	3.41	14.24	18.19	0.03	0.56
Interest Coverage	-	-	-	-	-	-	-8.97	-6.88	-42.58
Return on Equity (ROE)	-183.30%	-183.30%	-186.20%	-367.30%	-171.40%	-91.20%	-675.50%	207.00%	-
Return on Assets (ROA)	-134.10%	-134.10%	-132.80%	-224.50%	-149.80%	-86.10%	-491.40%	-1224.70%	-
Return on Capital (ROIC)	-168.68%	-168.68%	-331.44%	-512.35%	-274.15%	-115.47%	-157.32%	322.84%	-314.16%
Earnings Yield	-78.48%	-226.15%	-220.51%	-34.64%	-45.07%	-34.55%	-34.65%	-	-
FCF Yield	-104.27%	-300.46%	-193.74%	-21.43%	-31.58%	-25.49%	-7.44%	-	-
Buyback Yield / Dilution	-42.25%	-42.25%	-34.69%	-49.15%	-26.50%	-107.01%	-45.80%	-0.20%	-
Total Shareholder Return	-42.25%	-42.25%	-34.69%	-49.15%	-26.50%	-107.01%	-45.80%	-0.20%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).